Sharper radiation beams aim to tame High-Risk prostate cancer

NCT ID NCT02177292

Ongoing Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a newer, highly precise radiation technique for men with high-risk prostate cancer. The treatment delivers a strong dose to the pelvic lymph nodes while boosting radiation to the prostate itself. Researchers want to see if this approach controls the cancer better and causes fewer side effects than standard radiation. The trial enrolled 80 participants and is no longer recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT)
What this could lead to: If successful, this approach could offer a more effective and precise radiation treatment for high-risk prostate cancer, potentially improving disease control and reducing side effects.
What could go wrong: This is a small, early-phase trial (80 people) with no comparison group, so results may not apply to all patients. Radiation can still cause side effects like bowel or bladder issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Froedtert & the Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.